Lv1
90 积分 2024-09-12 加入
Current Evidence in the Management of Recurrent Breast Cancer
24天前
已完结
Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors
1个月前
已完结
Interferon-induced senescent CD8 + T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer
1个月前
已完结
Breast cancer-targeted therapy and doxorubicin multidrug resistance are reversed via macrophage membrane-camouflaged liposomes
1个月前
已完结
Understanding and overcoming multidrug resistance in cancer
1个月前
已完结
Impacts of competition and phenotypic plasticity on the viability of adaptive therapy
1个月前
已关闭
Gemcitabine Resistant Triple Negative Breast Tumor Derived Mesoporous Silicon Nanovaccine Overcame Drug Resistance
1个月前
已完结
Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial
1个月前
已完结
Targeting Protein Kinase, Membrane-Associated Tyrosine/Threonine 1 (PKMYT1) for Precision Cancer Therapy: From Discovery to Clinical Trial
2个月前
已完结
Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306
2个月前
已完结
皖公网安备34019202002308
